Back to search

Netherlands· NL-75b4897746ff

Envarsus 4 mg, tablet met verlengde afgifte

A tacrolimus product containing tacrolimus 1-water, registered in Netherlands by Chiesi Farmaceutici S.P.A. The same ATC class is registered in 16 of our 19 countries.

ATC L04AD02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedEnvarsus 4 mg, tablet met verlengde a…ATCL04AD02REGISTER NO.NL-75b4897746ffPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Tacrolimus is registered in 16 of 19 countries.

Countries holding a registration under ATC L04AD02 (tacrolimus), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 9 of them publish a price we can compare per daily dose

Tacrolimus · ATC L04AD02

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tacrolimus costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.77 in United States to $16.77 in Switzerland — a ×22 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Tacrolimus · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$16.77
  • IT Italy$8.99
  • US United States$0.77 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TACROLIMUS 1-WATER
Manufacturer
Chiesi Farmaceutici S.P.A
Country
Netherlands (NL)
ATC code
L04AD02
ATC class
Tacrolimus
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/14/935

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1075 interactions on record for tacrolimus.

Graded by severity as the source publishes them — 238 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Tacrolimus · interactions on record

1075 records

  • 238 severe
  • 543 moderate
  • 18 minor
  • 217 info

Most severe, free to view

  • ClotrimazoleA01AB18severe
  • OmeprazoleA02BC01severe
  • LansoprazoleA02BC03severe
  • EsomeprazoleA02BC05severe

59 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tacrolimus in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tacrolimus products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Adport, Dailiport
  • Belgium · Adoport, Dailiport
  • Bulgaria · Програф
  • Cyprus · Prograf, Tacrolimus Accord
  • Czechia · Dailiport, Gecrol
  • Germany · Crilomus, Dailiport
  • Denmark · Adport, Dailiport
  • Estonia · Dailiport, Lebsanan
  • Spain · Adoport, Cellmune
  • Finland · Adport, Adport,
  • France · Adoport, Conferoport
  • United Kingdom (Northern Ireland) · Adoport, Ascezo
  • Greece · Atodrit-Dermo, Eczatope Derm
  • Croatia · Atezyrix, Dermitopic
  • Hungary · Prograf, Tacrolimus Stada
  • Ireland · Prograf, Tacrolimus Accord
  • Iceland · Advagraf, Dailiport
  • Italy · Adoport, Carelimus
  • Liechtenstein · Advagraf, Envarsus
  • Lithuania · Dailiport, Lebsanan
  • Luxembourg · Prograft, Sumilor
  • Latvia · Dailiport, Lebsanan
  • Malta · Prograf
  • Norway · Adport, Advagraf
  • Poland · Cidimus, Dailiport
  • Portugal · Adoport, Dermitopic
  • Romania · Prograf, Tacrolimus Sandoz
  • Sweden · Adport, Adport,
  • Slovenia · Adoport, Dailiport
  • Slovakia · Atezyrix, Dailiport

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9b08bfd6-3f13-4a76-9776-cb96dbdde249
GET /v1/drugs/9b08bfd6-3f13-4a76-9776-cb96dbdde249?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet met verlengde afgifte",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/envarsus-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Tacrolimus",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp113812",
  "excipients": [
    "BUTYLHYDROXYTOLUEEN (E 321)",
    "DIMETICON (E 900)",
    "HYPROMELLOSE (Release controlling polymer)(E 464)",
    "LACTOSE 1-WATER",
    "MACROGOL 6000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POLOXAMEER 188",
    "WIJNSTEENZUUR, (L (+) Vorm) (E 334)"
  ],
  "substances": [
    "TACROLIMUS 1-WATER"
  ],
  "leaflet_url": null,
  "authorised_at": "2014/07/18",
  "procedure_number": "EMEA/H/C/002655",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/14/935",
  "additional_monitoring": "N"
}

See everything about tacrolimus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.